Literature DB >> 16819550

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

Paul Gregorevic1, James M Allen, Elina Minami, Michael J Blankinship, Miki Haraguchi, Leonard Meuse, Eric Finn, Marvin E Adams, Stanley C Froehner, Charles E Murry, Jeffrey S Chamberlain.   

Abstract

Mice carrying mutations in both the dystrophin and utrophin genes die prematurely as a consequence of severe muscular dystrophy. Here, we show that intravascular administration of recombinant adeno-associated viral (rAAV) vectors carrying a microdystrophin gene restores expression of dystrophin in the respiratory, cardiac and limb musculature of these mice, considerably reducing skeletal muscle pathology and extending lifespan. These findings suggest rAAV vector-mediated systemic gene transfer may be useful for treatment of serious neuromuscular disorders such as Duchenne muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819550      PMCID: PMC4244883          DOI: 10.1038/nm1439

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  15 in total

1.  Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector.

Authors:  J P Greelish; L T Su; E B Lankford; J M Burkman; H Chen; S K Konig; I M Mercier; P R Desjardins; M A Mitchell; X G Zheng; J Leferovich; G P Gao; R J Balice-Gordon; J M Wilson; H H Stedman
Journal:  Nat Med       Date:  1999-04       Impact factor: 53.440

2.  Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.

Authors:  J M Allen; C L Halbert; A D Miller
Journal:  Mol Ther       Date:  2000-01       Impact factor: 11.454

3.  Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.

Authors:  Paul Gregorevic; David R Plant; Kerri S Leeding; Leon A Bach; Gordon S Lynch
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

Authors:  Paul Gregorevic; Michael J Blankinship; James M Allen; Robert W Crawford; Leonard Meuse; Daniel G Miller; David W Russell; Jeffrey S Chamberlain
Journal:  Nat Med       Date:  2004-07-25       Impact factor: 53.440

Review 5.  Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy.

Authors:  D Gozal
Journal:  Pediatr Pulmonol       Date:  2000-02

6.  Muscle and tendon force-length properties and their interactions in vivo.

Authors:  D Hawkins; M Bey
Journal:  J Biomech       Date:  1997-01       Impact factor: 2.712

7.  Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.

Authors:  J A Rafael; J M Tinsley; A C Potter; A E Deconinck; K E Davies
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

8.  Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy.

Authors:  A E Deconinck; J A Rafael; J A Skinner; S C Brown; A C Potter; L Metzinger; D J Watt; J G Dickson; J M Tinsley; K E Davies
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.

Authors:  Scott Q Harper; Michael A Hauser; Christiana DelloRusso; Dongsheng Duan; Robert W Crawford; Stephanie F Phelps; Hollie A Harper; Ann S Robinson; John F Engelhardt; Susan V Brooks; Jeffrey S Chamberlain
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

10.  The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.

Authors:  H H Stedman; H L Sweeney; J B Shrager; H C Maguire; R A Panettieri; B Petrof; M Narusawa; J M Leferovich; J T Sladky; A M Kelly
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

View more
  153 in total

1.  Dystrophin immunity in Duchenne's muscular dystrophy.

Authors:  Jerry R Mendell; Katherine Campbell; Louise Rodino-Klapac; Zarife Sahenk; Chris Shilling; Sarah Lewis; Dawn Bowles; Steven Gray; Chengwen Li; Gloria Galloway; Vinod Malik; Brian Coley; K Reed Clark; Juan Li; Xiao Xiao; Jade Samulski; Scott W McPhee; R Jude Samulski; Christopher M Walker
Journal:  N Engl J Med       Date:  2010-10-07       Impact factor: 91.245

2.  Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy.

Authors:  Yuko Nitahara-Kasahara; Hiromi Hayashita-Kinoh; Sachiko Ohshima-Hosoyama; Hironori Okada; Michiko Wada-Maeda; Akinori Nakamura; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

Review 3.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

4.  Signs of progress in gene therapy for muscular dystrophy also warrant caution.

Authors:  Hansell H Stedman; Barry J Byrne
Journal:  Mol Ther       Date:  2012-02       Impact factor: 11.454

5.  Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice.

Authors:  Y Tang; D P Reay; M N Salay; M Y Mi; P R Clemens; D C Guttridge; P D Robbins; J Huard; B Wang
Journal:  Gene Ther       Date:  2010-08-19       Impact factor: 5.250

Review 6.  Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials.

Authors:  Yuko Shimizu-Motohashi; Shouta Miyatake; Hirofumi Komaki; Shin'ichi Takeda; Yoshitsugu Aoki
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

7.  A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection.

Authors:  Lin Yang; Jiangang Jiang; Lauren M Drouin; Mavis Agbandje-McKenna; Chunlian Chen; Chunping Qiao; Dongqiuye Pu; Xiaoyun Hu; Da-Zhi Wang; Juan Li; Xiao Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

Review 8.  Update on the treatment of Duchenne muscular dystrophy.

Authors:  Louise R Rodino-Klapac; Jerry R Mendell; Zarife Sahenk
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

9.  AAV-8 is more efficient than AAV-9 in transducing neonatal dog heart.

Authors:  Xiufang Pan; Yongping Yue; Keqing Zhang; Chady H Hakim; Kasun Kodippili; Thomas McDonald; Dongsheng Duan
Journal:  Hum Gene Ther Methods       Date:  2015-04-01       Impact factor: 2.396

10.  Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.

Authors:  Brian Bostick; Yongping Yue; Yi Lai; Chun Long; Dejia Li; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.